Cusato Jessica, Manca Alessandra, Palermiti Alice, Mula Jacopo, Costanzo Martina, Antonucci Miriam, Chiara Francesco, De Vivo Elisa Delia, Maiese Domenico, Ferrara Micol, Bonora Stefano, Di Perri Giovanni, D'Avolio Antonio, Calcagno Andrea
Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera, 164, 10149 Turin, Italy.
ASL Città di Torino, Amedeo di Savoia Hospital, 10149 Turin, Italy.
Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
An uncontrolled inflammatory response during SARS-CoV-2 infection has been highlighted in several studies. This seems to be due to pro-inflammatory cytokines whose production could be regulated by vitamin D, ROS production or mitogen-activated protein kinase (MAPK). Several genetic studies are present in the literature concerning genetic influences on COVID-19 characteristics, but there are few data on oxidative stress, vitamin D, MAPK and inflammation-related factors, considering gender and age. Therefore, the aim of this study was to evaluate the role of single nucleotide polymorphisms in these pathways, clarifying their impact in affecting COVID-19-related clinical features. Genetic polymorphisms were evaluated through real-time PCR. We prospectively enrolled 160 individuals: 139 patients were positive for SARS-CoV-2 detection. We detected different genetic variants able to affect the symptoms and oxygenation. Furthermore, two sub-analyses were performed considering gender and age, showing a different impact of polymorphisms according to these characteristics. This is the first study highlighting a possible contribution of genetic variants of these pathways in affecting COVID-19 clinical features. This may be relevant in order to clarify the COVID-19 etiopathogenesis and to understand the possible genetic contribution for further SARS infections.
多项研究强调了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染期间不受控制的炎症反应。这似乎是由于促炎细胞因子,其产生可能受维生素D、活性氧(ROS)产生或丝裂原活化蛋白激酶(MAPK)调节。文献中有几项关于基因对2019冠状病毒病(COVID-19)特征影响的基因研究,但考虑到性别和年龄,关于氧化应激、维生素D、MAPK和炎症相关因子的数据很少。因此,本研究的目的是评估这些途径中单核苷酸多态性的作用,阐明它们对COVID-19相关临床特征的影响。通过实时聚合酶链反应(PCR)评估基因多态性。我们前瞻性地招募了160名个体:139名患者SARS-CoV-2检测呈阳性。我们检测到了能够影响症状和氧合的不同基因变异。此外,根据性别和年龄进行了两项亚分析,结果显示多态性根据这些特征产生了不同的影响。这是第一项强调这些途径的基因变异可能对COVID-19临床特征产生影响的研究。这对于阐明COVID-19的发病机制以及了解进一步SARS感染的可能遗传贡献可能具有重要意义。